Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment

por Yeung, Tsz-Lun, Leung, Cecilia S., Li, Fuhai, Wong, Stephen T. C., Mok, Samuel C.
Publicado 2016

ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells

por Yeung, Tsz-Lun, Leung, Cecilia S., Wong, Kwong-Kwok, Gutierrez-Hartmann, Arthur, Kwong, Joseph, Gershenson, David M., Mok, Samuel C.
Publicado 2017

Systematic Identification of Druggable Epithelial–Stromal Crosstalk Signaling Networks in Ovarian Cancer

por Yeung, Tsz-Lun, Sheng, Jianting, Leung, Cecilia S, Li, Fuhai, Kim, Jaeyeon, Ho, Samuel Y, Matzuk, Martin M, Lu, Karen H, Wong, Stephen T C, Mok, Samuel C
Publicado 2018

ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression

por Yeung, Tsz-Lun, Tsai, Ching Chou, Leung, Cecilia S., Au Yeung, Chi-Lam, Thompson, Melissa S., Lu, Karen H., Freedman, Ralph S., Birrer, Michael J., Wong, Kwong-Kwok, Mok, Samuel C.
Publicado 2018

Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression

por Kwan, Suet-Ying, Au-Yeung, Chi-Lam, Yeung, Tsz-Lun, Rynne-Vidal, Angela, Wong, Kwong-Kwok, Risinger, John I., Lin, Hui-Kuan, Schmandt, Rosemarie E., Yates, Melinda S., Mok, Samuel C., Lu, Karen H.
Publicado 2020

SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment

por Zhu, Ying, Ferri-Borgogno, Sammy, Sheng, Jianting, Yeung, Tsz-Lun, Burks, Jared K., Cappello, Paola, Jazaeri, Amir A., Kim, Jae-Hoon, Han, Gwan Hee, Birrer, Michael J., Mok, Samuel C., Wong, Stephen T. C.
Publicado 2021

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

por Au Yeung, Chi Lam, Co, Ngai-Na, Tsuruga, Tetsushi, Yeung, Tsz-Lun, Kwan, Suet-Ying, Leung, Cecilia S., Li, Yong, Lu, Edward S., Kwan, Kenny, Wong, Kwong-Kwok, Schmandt, Rosemarie, Lu, Karen H., Mok, Samuel C.
Publicado 2016

Calcium Dependent FAK/CREB/TNNC1 Signaling Mediates the Effect of Stromal MFAP5 on Ovarian Cancer Metastatic Potential

por Leung, Cecilia S., Yeung, Tsz-Lun, Yip, Kay-Pong, Pradeep, Sunila, Balasubramanian, Lavanya, Liu, Jinsong, Wong, Kwong-Kwok, Mangala, Lingegowda S., Armaiz-Pena, Guillermo N., Lopez-Berestein, Gabriel, Sood, Anil K., Birrer, Michael J., Mok, Samuel C.
Publicado 2014

Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers

por Osmanbeyoglu, Hatice U., Shimizu, Fumiko, Rynne-Vidal, Angela, Alonso-Curbelo, Direna, Chen, Hsuan-An, Wen, Hannah Y., Yeung, Tsz-Lun, Jelinic, Petar, Razavi, Pedram, Lowe, Scott W., Mok, Samuel C., Chiosis, Gabriela, Levine, Douglas A., Leslie, Christina S.
Publicado 2019

Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer

por Rynne‐Vidal, Angela, Au‐Yeung, Chi Lam, Jiménez‐Heffernan, José A, Pérez‐Lozano, María Luisa, Cremades‐Jimeno, Lucía, Bárcena, Carmen, Cristóbal‐García, Ignacio, Fernández‐Chacón, Concepción, Yeung, Tsz Lun, Mok, Samuel C, Sandoval, Pilar, López‐Cabrera, Manuel
Publicado 2017

Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype

por Hu, Wen, Zhang, Li, Ferri-Borgogno, Sammy, Kwan, Suet-Ying, Lewis, Kelsey E., Cun, Han T., Yeung, Tsz-Lun, Soliman, Pamela T., Tarapore, Rohinton S., Allen, Joshua E., Guan, Xinyuan, Lu, Karen H., Mok, Samuel C., Au-Yeung, Chi-Lam
Publicado 2020

Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436

por Hu, Wen, Zhang, Li, Ferri-Borgogno, Sammy, Kwan, Suet-Ying, Lewis, Kelsey E., Cun, Han T., Yeung, Tsz-Lun, Soliman, Pamela T., Tarapore, Rohinton S., Allen, Joshua E., Guan, Xinyuan, Lu, Karen H., Mok, Samuel C., Au-Yeung, Chi-Lam
Publicado 2021

Ryanodine receptor 1-mediated Ca(2+) signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes

por Zhang, Li, Au-Yeung, Chi-Lam, Huang, Chunxian, Yeung, Tsz-Lun, Ferri-Borgogno, Sammy, Lawson, Barrett C., Kwan, Suet-Ying, Yin, Zheng, Wong, Stephen T., Thomas, Vienna, Lu, Karen H., Yip, Kay-Pong, Sham, James S. K., Mok, Samuel C.
Publicado 2022

ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment

por Au-Yeung, Chi-Lam, Yeung, Tsz-Lun, Achreja, Abhinav, Zhao, Hongyun, Yip, Kay-Pong, Kwan, Suet-Ying, Onstad, Michaela, Sheng, Jianting, Zhu, Ying, Baluya, Dodge L., Co, Ngai-Na, Rynne-Vidal, Angela, Schmandt, Rosemarie, Anderson, Matthew L., Lu, Karen H., Wong, Stephen T. C., Nagrath, Deepak, Mok, Samuel C.
Publicado 2020

Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses

por Lan, Yan, Yeung, Tsz-Lun, Huang, Hui, Wegener, Ansgar A, Saha, Somdutta, Toister-Achituv, Mira, Jenkins, Molly H, Chiu, Li-Ya, Lazorchak, Adam, Tarcic, Ohad, Wang, Hong, Qi, Jin, Locke, George, Kalimi, Doron, Qin, Guozhong, Marelli, Bo, Yu, Huakui, Gross, Alec W, Derner, Melissa G, Soloviev, Maria, Botte, Mathieu, Sircar, Aroop, Ma, Hong, Sood, Vanita D, Zhang, Dong, Jiang, Feng, Lo, Kin-Ming
Publicado 2022